Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and
is now an acceptable treatment option for patients with advanced coronary artery disease …

Background The optimal revascularization strategy for the elderly with complex coronary
artery disease remains unclear. Objectives The goal of this study was to investigate 10-year …

Atherosclerotic cardiovascular diseases are the leading cause of adverse outcomes in
patients with type 2 diabetes, and all new anti-diabetic agents are mandated to undergo …

Background Several trials reported differential outcomes after percutaneous coronary
intervention with drug‐eluting stents (DES) and coronary‐artery bypass grafting (CABG) for …

There is a scarcity of data comparing long-term clinical outcomes between percutaneous
coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with …

Three ‑year mortality after acute myocardial infarction in patients with different diabetic status
Page 1 ORIGINAL ARTICLE Mortality after myocardial infarction in different diabetic status 1 …

As percutaneous coronary intervention (PCI) continues to evolve, comparative outcomes for
PCI vs coronary artery bypass grafting (CABG) remain relevant in diabetic patients. All …

OBJECTIVES We analysed the Veteran Affairs data to evaluate the association of pre-
operative glycated haemoglobin (HbA1c) and long-term outcome after isolated coronary …

Background Patients with diabetes and triple-vessel disease (TVD) are associated with a
high risk of events. The choice of treatment strategies remains a subject of discussion. In the …

OBJECTIVES In this post hoc analysis of the Ticagrelor in coronary artery bypass grafting
(CABG) trial, we aimed to analyse patients treated with CABG receiving either complete …